Select Country

 
877-783-6728 (877-StemSave)

StemSave Blog

Clinical Trial for RP Patients Completes Patient Enrollment

Posted by [email protected] on Dec 13, 2016 3:00:00 PM

California’s Institute for Regenerative Medicine (CIRM) has announced the completion of patient enrollment in a study testing a stem cell derived therapy for retinitis pigmentosa (RP) patients. The treatment involves injecting human retinal progenitor cells into the damaged area of the retina to improve vision. These progenitor cells could either replace the damaged photoreceptors in the eye, or prevent them from being destroyed.

Read More

Topics: clinical trials, Retinitis Pigmentosa, regenerative medicine, stem cells

Retinitis Pigmentosa Stem Cell Protocol Goes into Clinical Trials

Posted by [email protected] on Nov 5, 2015 2:03:00 PM

Dr. Henry Klassen of UC Irvine has initiated an FDA approved stem cell based clinical trial for the treatment of Retinitis Pigmentosa (RP) through the regeneration of damaged retinal tissue. RP is caused by the slow decay of photoreceptors in the retina, which provide vital chemical communication to the brain. The disease is thought to derive from mutations in genes responsible for rods and cones, which ultimately lead to blindness. There is no current treatment for RP.

Read More

Topics: stemsaveblog, Retinitis Pigmentosa, Eyes, clinical trial, retinal blindness, mesenchymal stem cells

AAOMS

AAOMS - American Association of Oral and Maxillofacial Surgeons

 

As the industry leader, StemSave is the only stem cell banking service to be designated as an ASI approved program.

Subscribe to Email Updates

Join our Newsletter

Posts by Topic

see all